Celleration, Inc. Receives 2005 Tekne Award For Emerging Biotechnology Company; Tekne Awards Honor Key Leaders And Innovators In Minnesota Technology Industries
MINNEAPOLIS, Nov. 16 /PRNewswire/ -- Celleration, Inc. today announced it was named as an award recipient in the Emerging Biotechnology category at the 2005 Tekne Awards held at the Minneapolis Convention Center on November 10, 2005. The Tekne Awards recognize Minnesota's outstanding technology achievements and leaders.
"We are honored to be selected as a recipient of a 2005 Tekne Award, and also recognized as an emerging biotechnology leader in Minnesota," said Kevin Nickels, CEO of Celleration. "We are proud to receive this award on behalf of all our talented colleagues at Celleration. Under the strong leadership of our management team, the innovative group at Celleration has developed the MIST Therapy(R) System to improve the treatment of chronic and hard to heal wounds."
Celleration's proprietary non-contact ultrasound MIST Technology(TM) can be used on a variety of wounds including, acute, traumatic, chronic and dehisced wounds to promote wound healing. The use of MIST Therapy is an attractive technology for health care professionals since its use appears to affect multiple aspects of a chronic wound to optimize the wound bed environment thus promoting healing. The treatment takes only minutes; it is easy to use, compact and portable, and comfortable for patients with painful wounds.
Sponsored jointly by The Minnesota High Tech Association (MHTA) and Minnesota Technology, Inc. (MTI) -- and in partnership with Medical Alley/MNBIO -- The Minnesota Tekne Awards honor companies, innovations and individuals that positively impact Minnesota's technology-based economy. The awards are given to recognize innovation, development, commercialization, and management of technology in the State of Minnesota.
Tekne Awards are separated into emerging and established company categories, recognizing the best and brightest in innovation, development, education, commercialization and management of technology in Minnesota. This year's awards featured 51 finalists in 17 categories. A list of all recipients and finalists is available online at http://www.tekneawards.org .
About Celleration, Inc.
Celleration, Inc. a privately held medical device company was founded in 1999, to develop and commercialize its therapeutic ultrasound platform. The patented MIST Technology utilizes low intensity ultrasonic sound waves to produce an energized mist of sterile saline in a non-contact fashion. Critical to the Company's strategy is ongoing clinical and scientific research to provide evidence supporting the efficacy of this new technology.
Celleration, Inc.CONTACT: Kevin Nickels, President and CEO of Celleration, Inc.,+1-952-224-8700